Another study by Watson et al. (2019) examined the effect of GLP-1 on the brain in a different group: middle-aged adults at risk for Alzheimer's disease (AD), many of whom had insulin resistance [11]. The gene discussed is GLP1R; the disease is Alzheimer disease.